nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprost Tromethamine—SLCO3A1—Methotrexate—esophageal cancer	0.28	0.432	CbGbCtD
Dinoprost Tromethamine—SLC22A2—Cisplatin—esophageal cancer	0.0967	0.149	CbGbCtD
Dinoprost Tromethamine—SLC22A11—Methotrexate—esophageal cancer	0.0925	0.143	CbGbCtD
Dinoprost Tromethamine—SLC22A7—Methotrexate—esophageal cancer	0.0881	0.136	CbGbCtD
Dinoprost Tromethamine—SLC22A8—Methotrexate—esophageal cancer	0.0538	0.0829	CbGbCtD
Dinoprost Tromethamine—SLC22A6—Methotrexate—esophageal cancer	0.0375	0.0578	CbGbCtD
Dinoprost Tromethamine—Venous thrombosis—Carboplatin—esophageal cancer	0.00783	0.0845	CcSEcCtD
Dinoprost Tromethamine—Fluid overload—Carboplatin—esophageal cancer	0.0068	0.0733	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—epithelium—esophageal cancer	0.00513	0.0656	CbGeAlD
Dinoprost Tromethamine—Extravasation—Carboplatin—esophageal cancer	0.00485	0.0523	CcSEcCtD
Dinoprost Tromethamine—PTGER3—smooth muscle tissue—esophageal cancer	0.0038	0.0486	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—neck—esophageal cancer	0.00357	0.0457	CbGeAlD
Dinoprost Tromethamine—Phlebitis—Carboplatin—esophageal cancer	0.00356	0.0384	CcSEcCtD
Dinoprost Tromethamine—HPGDS—epithelium—esophageal cancer	0.00341	0.0436	CbGeAlD
Dinoprost Tromethamine—TBXA2R—lung—esophageal cancer	0.00326	0.0417	CbGeAlD
Dinoprost Tromethamine—PTGFR—bronchus—esophageal cancer	0.00311	0.0397	CbGeAlD
Dinoprost Tromethamine—PTGFR—smooth muscle tissue—esophageal cancer	0.00304	0.0389	CbGeAlD
Dinoprost Tromethamine—PTGER3—digestive system—esophageal cancer	0.003	0.0384	CbGeAlD
Dinoprost Tromethamine—PTGFR—trachea—esophageal cancer	0.00279	0.0357	CbGeAlD
Dinoprost Tromethamine—PTGIR—epithelium—esophageal cancer	0.00278	0.0356	CbGeAlD
Dinoprost Tromethamine—PTGIR—smooth muscle tissue—esophageal cancer	0.00268	0.0343	CbGeAlD
Dinoprost Tromethamine—Vasospasm—Capecitabine—esophageal cancer	0.00268	0.0289	CcSEcCtD
Dinoprost Tromethamine—HPGDS—digestive system—esophageal cancer	0.00259	0.0332	CbGeAlD
Dinoprost Tromethamine—PTGER3—lung—esophageal cancer	0.00251	0.0321	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—epithelium—esophageal cancer	0.00243	0.0311	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—bronchus—esophageal cancer	0.00242	0.0309	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—bronchus—esophageal cancer	0.00239	0.0306	CbGeAlD
Dinoprost Tromethamine—Venous thrombosis—Cisplatin—esophageal cancer	0.0023	0.0248	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—lymph node—esophageal cancer	0.00223	0.0285	CbGeAlD
Dinoprost Tromethamine—HPGDS—lung—esophageal cancer	0.00217	0.0277	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—trachea—esophageal cancer	0.00215	0.0275	CbGeAlD
Dinoprost Tromethamine—PTGIR—digestive system—esophageal cancer	0.00212	0.0271	CbGeAlD
Dinoprost Tromethamine—Ileus paralytic—Capecitabine—esophageal cancer	0.00211	0.0228	CcSEcCtD
Dinoprost Tromethamine—SLC22A11—digestive system—esophageal cancer	0.00206	0.0264	CbGeAlD
Dinoprost Tromethamine—SLC22A7—digestive system—esophageal cancer	0.00201	0.0257	CbGeAlD
Dinoprost Tromethamine—PTGFR—lung—esophageal cancer	0.002	0.0256	CbGeAlD
Dinoprost Tromethamine—Fluid overload—Cisplatin—esophageal cancer	0.00199	0.0215	CcSEcCtD
Dinoprost Tromethamine—SLC22A2—digestive system—esophageal cancer	0.00179	0.0229	CbGeAlD
Dinoprost Tromethamine—PTGIR—lung—esophageal cancer	0.00177	0.0226	CbGeAlD
Dinoprost Tromethamine—PTGER3—lymph node—esophageal cancer	0.00171	0.0219	CbGeAlD
Dinoprost Tromethamine—Venous thrombosis—Capecitabine—esophageal cancer	0.00169	0.0183	CcSEcCtD
Dinoprost Tromethamine—SLCO3A1—lung—esophageal cancer	0.00156	0.0199	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—lung—esophageal cancer	0.00154	0.0197	CbGeAlD
Dinoprost Tromethamine—Infection—Carboplatin—esophageal cancer	0.0015	0.0162	CcSEcCtD
Dinoprost Tromethamine—HPGDS—lymph node—esophageal cancer	0.00148	0.019	CbGeAlD
Dinoprost Tromethamine—Extravasation—Cisplatin—esophageal cancer	0.00142	0.0153	CcSEcCtD
Dinoprost Tromethamine—PTGFR—lymph node—esophageal cancer	0.00137	0.0175	CbGeAlD
Dinoprost Tromethamine—Pain—Carboplatin—esophageal cancer	0.00129	0.0139	CcSEcCtD
Dinoprost Tromethamine—Hiccups—Cisplatin—esophageal cancer	0.00124	0.0134	CcSEcCtD
Dinoprost Tromethamine—PTGIR—lymph node—esophageal cancer	0.00121	0.0155	CbGeAlD
Dinoprost Tromethamine—Body temperature increased—Carboplatin—esophageal cancer	0.00119	0.0129	CcSEcCtD
Dinoprost Tromethamine—Petechiae—Capecitabine—esophageal cancer	0.00111	0.012	CcSEcCtD
Dinoprost Tromethamine—Hypoxia—Methotrexate—esophageal cancer	0.00107	0.0116	CcSEcCtD
Dinoprost Tromethamine—SLCO3A1—lymph node—esophageal cancer	0.00107	0.0136	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—lymph node—esophageal cancer	0.00106	0.0135	CbGeAlD
Dinoprost Tromethamine—Phlebitis—Cisplatin—esophageal cancer	0.00104	0.0113	CcSEcCtD
Dinoprost Tromethamine—Cardiac failure congestive—Cisplatin—esophageal cancer	0.000993	0.0107	CcSEcCtD
Dinoprost Tromethamine—Burning sensation—Methotrexate—esophageal cancer	0.000979	0.0106	CcSEcCtD
Dinoprost Tromethamine—Cyanosis—Methotrexate—esophageal cancer	0.000961	0.0104	CcSEcCtD
Dinoprost Tromethamine—Hiccups—Capecitabine—esophageal cancer	0.000914	0.00986	CcSEcCtD
Dinoprost Tromethamine—Pulmonary embolism—Capecitabine—esophageal cancer	0.000914	0.00986	CcSEcCtD
Dinoprost Tromethamine—Tafluprost—PTGS2—esophageal cancer	0.000907	0.594	CrCbGaD
Dinoprost Tromethamine—Urinary incontinence—Capecitabine—esophageal cancer	0.000883	0.00952	CcSEcCtD
Dinoprost Tromethamine—Dehydration—Cisplatin—esophageal cancer	0.000837	0.00903	CcSEcCtD
Dinoprost Tromethamine—Petechiae—Methotrexate—esophageal cancer	0.000827	0.00892	CcSEcCtD
Dinoprost Tromethamine—Hypokalaemia—Cisplatin—esophageal cancer	0.000819	0.00884	CcSEcCtD
Dinoprost Tromethamine—Sepsis—Capecitabine—esophageal cancer	0.000793	0.00856	CcSEcCtD
Dinoprost Tromethamine—Extravasation—Methotrexate—esophageal cancer	0.00078	0.00841	CcSEcCtD
Dinoprost Tromethamine—Phlebitis—Capecitabine—esophageal cancer	0.00077	0.00831	CcSEcCtD
Dinoprost Tromethamine—Thrombophlebitis—Capecitabine—esophageal cancer	0.000767	0.00827	CcSEcCtD
Dinoprost Tromethamine—Diabetes mellitus—Capecitabine—esophageal cancer	0.000763	0.00823	CcSEcCtD
Dinoprost Tromethamine—Respiratory failure—Methotrexate—esophageal cancer	0.000693	0.00748	CcSEcCtD
Dinoprost Tromethamine—Pulmonary embolism—Methotrexate—esophageal cancer	0.000681	0.00734	CcSEcCtD
Dinoprost Tromethamine—Diplopia—Capecitabine—esophageal cancer	0.000664	0.00716	CcSEcCtD
Dinoprost Tromethamine—Bradycardia—Cisplatin—esophageal cancer	0.000634	0.00684	CcSEcCtD
Dinoprost Tromethamine—Cardiac arrest—Capecitabine—esophageal cancer	0.000631	0.00681	CcSEcCtD
Dinoprost Tromethamine—Dinoprostone—CYP19A1—esophageal cancer	0.000621	0.406	CrCbGaD
Dinoprost Tromethamine—Dehydration—Capecitabine—esophageal cancer	0.000617	0.00666	CcSEcCtD
Dinoprost Tromethamine—Hypokalaemia—Capecitabine—esophageal cancer	0.000604	0.00652	CcSEcCtD
Dinoprost Tromethamine—Sepsis—Methotrexate—esophageal cancer	0.000591	0.00637	CcSEcCtD
Dinoprost Tromethamine—Thrombophlebitis—Methotrexate—esophageal cancer	0.000571	0.00616	CcSEcCtD
Dinoprost Tromethamine—Diabetes mellitus—Methotrexate—esophageal cancer	0.000568	0.00613	CcSEcCtD
Dinoprost Tromethamine—Bronchospasm—Capecitabine—esophageal cancer	0.000564	0.00609	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Cisplatin—esophageal cancer	0.000562	0.00607	CcSEcCtD
Dinoprost Tromethamine—Dysuria—Capecitabine—esophageal cancer	0.000536	0.00579	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Cisplatin—esophageal cancer	0.000521	0.00562	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Cisplatin—esophageal cancer	0.000503	0.00543	CcSEcCtD
Dinoprost Tromethamine—Urinary tract infection—Capecitabine—esophageal cancer	0.000497	0.00536	CcSEcCtD
Dinoprost Tromethamine—Malaise—Cisplatin—esophageal cancer	0.000489	0.00527	CcSEcCtD
Dinoprost Tromethamine—Haematuria—Capecitabine—esophageal cancer	0.000488	0.00526	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Capecitabine—esophageal cancer	0.000482	0.0052	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Cisplatin—esophageal cancer	0.00047	0.00507	CcSEcCtD
Dinoprost Tromethamine—Bradycardia—Capecitabine—esophageal cancer	0.000467	0.00504	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Cisplatin—esophageal cancer	0.000456	0.00492	CcSEcCtD
Dinoprost Tromethamine—Infection—Cisplatin—esophageal cancer	0.00044	0.00474	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Cisplatin—esophageal cancer	0.000432	0.00466	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Cisplatin—esophageal cancer	0.000428	0.00461	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Capecitabine—esophageal cancer	0.000416	0.00449	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Capecitabine—esophageal cancer	0.000415	0.00447	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Cisplatin—esophageal cancer	0.000413	0.00446	CcSEcCtD
Dinoprost Tromethamine—Chills—Capecitabine—esophageal cancer	0.000412	0.00444	CcSEcCtD
Dinoprost Tromethamine—Dysuria—Methotrexate—esophageal cancer	0.000399	0.00431	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Cisplatin—esophageal cancer	0.000397	0.00429	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Cisplatin—esophageal cancer	0.000394	0.00426	CcSEcCtD
Dinoprost Tromethamine—Back pain—Capecitabine—esophageal cancer	0.000387	0.00417	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Capecitabine—esophageal cancer	0.000384	0.00414	CcSEcCtD
Dinoprost Tromethamine—Drowsiness—Methotrexate—esophageal cancer	0.000381	0.00411	CcSEcCtD
Dinoprost Tromethamine—Pain—Cisplatin—esophageal cancer	0.000378	0.00408	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Capecitabine—esophageal cancer	0.000371	0.004	CcSEcCtD
Dinoprost Tromethamine—Sweating—Methotrexate—esophageal cancer	0.000365	0.00394	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Cisplatin—esophageal cancer	0.000365	0.00393	CcSEcCtD
Dinoprost Tromethamine—Haematuria—Methotrexate—esophageal cancer	0.000363	0.00392	CcSEcCtD
Dinoprost Tromethamine—Malaise—Capecitabine—esophageal cancer	0.00036	0.00389	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Methotrexate—esophageal cancer	0.000359	0.00387	CcSEcCtD
Dinoprost Tromethamine—Syncope—Capecitabine—esophageal cancer	0.000358	0.00387	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Capecitabine—esophageal cancer	0.000351	0.00379	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Cisplatin—esophageal cancer	0.00035	0.00377	CcSEcCtD
Dinoprost Tromethamine—Cough—Capecitabine—esophageal cancer	0.000349	0.00376	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Capecitabine—esophageal cancer	0.000345	0.00372	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Capecitabine—esophageal cancer	0.00034	0.00367	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Capecitabine—esophageal cancer	0.000336	0.00363	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Cisplatin—esophageal cancer	0.000326	0.00352	CcSEcCtD
Dinoprost Tromethamine—Infection—Capecitabine—esophageal cancer	0.000324	0.0035	CcSEcCtD
Dinoprost Tromethamine—Shock—Capecitabine—esophageal cancer	0.000321	0.00346	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Capecitabine—esophageal cancer	0.000318	0.00343	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Cisplatin—esophageal cancer	0.000317	0.00342	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Capecitabine—esophageal cancer	0.000315	0.0034	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Methotrexate—esophageal cancer	0.00031	0.00334	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Methotrexate—esophageal cancer	0.000309	0.00333	CcSEcCtD
Dinoprost Tromethamine—Chills—Methotrexate—esophageal cancer	0.000307	0.00331	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Capecitabine—esophageal cancer	0.000305	0.00329	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Cisplatin—esophageal cancer	0.000303	0.00327	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Capecitabine—esophageal cancer	0.000293	0.00316	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Capecitabine—esophageal cancer	0.000291	0.00314	CcSEcCtD
Dinoprost Tromethamine—Back pain—Methotrexate—esophageal cancer	0.000288	0.0031	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Cisplatin—esophageal cancer	0.000281	0.00303	CcSEcCtD
Dinoprost Tromethamine—Rash—Cisplatin—esophageal cancer	0.000279	0.00301	CcSEcCtD
Dinoprost Tromethamine—Pain—Capecitabine—esophageal cancer	0.000279	0.00301	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Cisplatin—esophageal cancer	0.000279	0.00301	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Methotrexate—esophageal cancer	0.000276	0.00298	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Capecitabine—esophageal cancer	0.000269	0.0029	CcSEcCtD
Dinoprost Tromethamine—Malaise—Methotrexate—esophageal cancer	0.000268	0.00289	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000267	0.00288	CcSEcCtD
Dinoprost Tromethamine—Nausea—Cisplatin—esophageal cancer	0.000263	0.00284	CcSEcCtD
Dinoprost Tromethamine—Cough—Methotrexate—esophageal cancer	0.00026	0.0028	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Capecitabine—esophageal cancer	0.000258	0.00278	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Capecitabine—esophageal cancer	0.000258	0.00278	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Methotrexate—esophageal cancer	0.000258	0.00278	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Methotrexate—esophageal cancer	0.000253	0.00273	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Methotrexate—esophageal cancer	0.00025	0.0027	CcSEcCtD
Dinoprost Tromethamine—Infection—Methotrexate—esophageal cancer	0.000241	0.0026	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Capecitabine—esophageal cancer	0.00024	0.00259	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Methotrexate—esophageal cancer	0.000235	0.00253	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Capecitabine—esophageal cancer	0.000234	0.00252	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Capecitabine—esophageal cancer	0.000231	0.00249	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Methotrexate—esophageal cancer	0.000227	0.00245	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Capecitabine—esophageal cancer	0.000223	0.00241	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Methotrexate—esophageal cancer	0.000218	0.00235	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Methotrexate—esophageal cancer	0.000216	0.00234	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Methotrexate—esophageal cancer	0.000216	0.00233	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Capecitabine—esophageal cancer	0.000216	0.00233	CcSEcCtD
Dinoprost Tromethamine—Pain—Methotrexate—esophageal cancer	0.000208	0.00224	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Capecitabine—esophageal cancer	0.000207	0.00224	CcSEcCtD
Dinoprost Tromethamine—Rash—Capecitabine—esophageal cancer	0.000206	0.00222	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Capecitabine—esophageal cancer	0.000205	0.00222	CcSEcCtD
Dinoprost Tromethamine—Headache—Capecitabine—esophageal cancer	0.000204	0.0022	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Methotrexate—esophageal cancer	0.0002	0.00216	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000199	0.00214	CcSEcCtD
Dinoprost Tromethamine—Nausea—Capecitabine—esophageal cancer	0.000194	0.00209	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Methotrexate—esophageal cancer	0.000192	0.00207	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Methotrexate—esophageal cancer	0.000192	0.00207	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Methotrexate—esophageal cancer	0.000179	0.00193	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Methotrexate—esophageal cancer	0.000174	0.00188	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Methotrexate—esophageal cancer	0.000172	0.00185	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Methotrexate—esophageal cancer	0.000166	0.00179	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Methotrexate—esophageal cancer	0.000161	0.00173	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Methotrexate—esophageal cancer	0.000154	0.00167	CcSEcCtD
Dinoprost Tromethamine—Rash—Methotrexate—esophageal cancer	0.000153	0.00165	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Methotrexate—esophageal cancer	0.000153	0.00165	CcSEcCtD
Dinoprost Tromethamine—Headache—Methotrexate—esophageal cancer	0.000152	0.00164	CcSEcCtD
Dinoprost Tromethamine—Nausea—Methotrexate—esophageal cancer	0.000144	0.00156	CcSEcCtD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—GHRL—esophageal cancer	7.56e-05	0.000424	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—GHRL—esophageal cancer	7.56e-05	0.000424	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PFN1—esophageal cancer	7.53e-05	0.000422	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PFN1—esophageal cancer	7.53e-05	0.000422	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—G alpha (q) signalling events—PIK3CA—esophageal cancer	7.41e-05	0.000415	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—NOS2—esophageal cancer	7.38e-05	0.000414	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—XIAP—esophageal cancer	7.36e-05	0.000413	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A11—Transmembrane transport of small molecules—HMOX1—esophageal cancer	7.29e-05	0.000409	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—PSME2—esophageal cancer	7.17e-05	0.000402	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—PSME1—esophageal cancer	7.17e-05	0.000402	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—ANXA1—esophageal cancer	7.13e-05	0.0004	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A11—Transmembrane transport of small molecules—ABCB1—esophageal cancer	7e-05	0.000392	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	7e-05	0.000392	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CTNNA1—esophageal cancer	6.96e-05	0.00039	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—HMOX1—esophageal cancer	6.96e-05	0.00039	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—TGFBR2—esophageal cancer	6.94e-05	0.000389	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—SST—esophageal cancer	6.94e-05	0.000389	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CXCL2—esophageal cancer	6.92e-05	0.000388	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—ELMO1—esophageal cancer	6.91e-05	0.000387	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—EP300—esophageal cancer	6.84e-05	0.000383	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	6.83e-05	0.000383	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	6.77e-05	0.000379	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—ELMO1—esophageal cancer	6.76e-05	0.000379	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—NOTCH3—esophageal cancer	6.76e-05	0.000379	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—GHRL—esophageal cancer	6.76e-05	0.000379	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—ELMO1—esophageal cancer	6.76e-05	0.000379	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—AKAP13—esophageal cancer	6.75e-05	0.000378	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—ABCB1—esophageal cancer	6.68e-05	0.000374	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—FBXW7—esophageal cancer	6.65e-05	0.000373	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—CREBBP—esophageal cancer	6.63e-05	0.000371	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	6.62e-05	0.000371	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—Transmembrane transport of small molecules—HMOX1—esophageal cancer	6.62e-05	0.000371	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—AKAP13—esophageal cancer	6.61e-05	0.00037	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—AKAP13—esophageal cancer	6.61e-05	0.00037	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—SMAD4—esophageal cancer	6.57e-05	0.000368	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PSME2—esophageal cancer	6.47e-05	0.000362	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PSME1—esophageal cancer	6.47e-05	0.000362	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—ANXA1—esophageal cancer	6.43e-05	0.000361	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—GNG7—esophageal cancer	6.35e-05	0.000356	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—Transmembrane transport of small molecules—ABCB1—esophageal cancer	6.35e-05	0.000356	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—SST—esophageal cancer	6.26e-05	0.000351	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—SLC52A3—esophageal cancer	6.24e-05	0.00035	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—BLVRB—esophageal cancer	6.24e-05	0.00035	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—HIST1H2BM—esophageal cancer	6.23e-05	0.000349	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PDE4D—esophageal cancer	6.18e-05	0.000346	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—HIST1H2BM—esophageal cancer	6.1e-05	0.000342	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—NOTCH3—esophageal cancer	6.1e-05	0.000342	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—HIST1H2BM—esophageal cancer	6.1e-05	0.000342	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—GHRL—esophageal cancer	6.1e-05	0.000342	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—NOTCH2—esophageal cancer	6.07e-05	0.00034	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PDE4D—esophageal cancer	6.05e-05	0.000339	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PDE4D—esophageal cancer	6.05e-05	0.000339	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—FBXW7—esophageal cancer	6e-05	0.000336	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—NOS3—esophageal cancer	5.94e-05	0.000333	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—GNG7—esophageal cancer	5.87e-05	0.000329	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—GNG7—esophageal cancer	5.75e-05	0.000322	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—GNG7—esophageal cancer	5.75e-05	0.000322	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—Transmembrane transport of small molecules—HMOX1—esophageal cancer	5.56e-05	0.000312	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—XIAP—esophageal cancer	5.51e-05	0.000308	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—NOTCH2—esophageal cancer	5.47e-05	0.000307	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—XIAP—esophageal cancer	5.39e-05	0.000302	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—XIAP—esophageal cancer	5.39e-05	0.000302	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—TGFBR2—esophageal cancer	5.38e-05	0.000302	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—HIF1A—esophageal cancer	5.38e-05	0.000301	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—Transmembrane transport of small molecules—ABCB1—esophageal cancer	5.34e-05	0.000299	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—SLC10A2—esophageal cancer	5.31e-05	0.000297	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CA1—esophageal cancer	5.31e-05	0.000297	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CTNNA1—esophageal cancer	5.21e-05	0.000292	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CXCL2—esophageal cancer	5.18e-05	0.00029	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—KDR—esophageal cancer	5.14e-05	0.000288	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CTNNA1—esophageal cancer	5.1e-05	0.000286	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CTNNA1—esophageal cancer	5.1e-05	0.000286	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—SMAD4—esophageal cancer	5.09e-05	0.000285	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CXCL2—esophageal cancer	5.07e-05	0.000284	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CXCL2—esophageal cancer	5.07e-05	0.000284	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—PIK3CA—esophageal cancer	5.06e-05	0.000283	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.05e-05	0.000283	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—TP53—esophageal cancer	4.89e-05	0.000274	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—TGFBR2—esophageal cancer	4.85e-05	0.000272	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CA2—esophageal cancer	4.85e-05	0.000272	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—NOTCH1—esophageal cancer	4.84e-05	0.000271	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PSME2—esophageal cancer	4.83e-05	0.000271	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PSME1—esophageal cancer	4.83e-05	0.000271	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—ANXA1—esophageal cancer	4.81e-05	0.00027	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PSME2—esophageal cancer	4.73e-05	0.000265	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PSME1—esophageal cancer	4.73e-05	0.000265	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PSME1—esophageal cancer	4.73e-05	0.000265	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PSME2—esophageal cancer	4.73e-05	0.000265	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—ANXA1—esophageal cancer	4.71e-05	0.000264	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—ANXA1—esophageal cancer	4.71e-05	0.000264	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—SST—esophageal cancer	4.68e-05	0.000262	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A11—Transmembrane transport of small molecules—CREBBP—esophageal cancer	4.68e-05	0.000262	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—HMOX1—esophageal cancer	4.64e-05	0.00026	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—SMAD4—esophageal cancer	4.59e-05	0.000257	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—SST—esophageal cancer	4.58e-05	0.000257	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—SST—esophageal cancer	4.58e-05	0.000257	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—NOTCH3—esophageal cancer	4.56e-05	0.000256	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—GHRL—esophageal cancer	4.56e-05	0.000256	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—EP300—esophageal cancer	4.52e-05	0.000253	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PLCE1—esophageal cancer	4.51e-05	0.000253	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—ADH7—esophageal cancer	4.51e-05	0.000253	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—FBXW7—esophageal cancer	4.49e-05	0.000251	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—NOTCH3—esophageal cancer	4.46e-05	0.00025	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—GHRL—esophageal cancer	4.46e-05	0.00025	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—GHRL—esophageal cancer	4.46e-05	0.00025	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—NOTCH3—esophageal cancer	4.46e-05	0.00025	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—CREBBP—esophageal cancer	4.46e-05	0.00025	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—ABCB1—esophageal cancer	4.46e-05	0.00025	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—FBXW7—esophageal cancer	4.39e-05	0.000246	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—FBXW7—esophageal cancer	4.39e-05	0.000246	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CREBBP—esophageal cancer	4.39e-05	0.000246	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—EGFR—esophageal cancer	4.31e-05	0.000242	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—Transmembrane transport of small molecules—CREBBP—esophageal cancer	4.25e-05	0.000238	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—HIF1A—esophageal cancer	4.17e-05	0.000234	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—PIK3CA—esophageal cancer	4.12e-05	0.000231	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—NOTCH2—esophageal cancer	4.09e-05	0.000229	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—NOTCH2—esophageal cancer	4e-05	0.000224	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—NOTCH2—esophageal cancer	4e-05	0.000224	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—NOS3—esophageal cancer	4e-05	0.000224	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—KDR—esophageal cancer	3.99e-05	0.000223	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—ADH1B—esophageal cancer	3.96e-05	0.000222	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—NOS3—esophageal cancer	3.93e-05	0.00022	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.87e-05	0.000217	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—TYMP—esophageal cancer	3.78e-05	0.000212	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—HIF1A—esophageal cancer	3.76e-05	0.000211	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—NOTCH1—esophageal cancer	3.75e-05	0.00021	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—PIK3CA—esophageal cancer	3.74e-05	0.00021	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	3.71e-05	0.000208	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CYP26A1—esophageal cancer	3.68e-05	0.000206	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—ERBB2—esophageal cancer	3.68e-05	0.000206	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—PTGS2—esophageal cancer	3.66e-05	0.000205	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—TGFBR2—esophageal cancer	3.63e-05	0.000203	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—KDR—esophageal cancer	3.6e-05	0.000201	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—ALOX15—esophageal cancer	3.58e-05	0.000201	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.57e-05	0.0002	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TGFBR2—esophageal cancer	3.55e-05	0.000199	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—TGFBR2—esophageal cancer	3.55e-05	0.000199	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—SMAD4—esophageal cancer	3.44e-05	0.000193	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—GSTO1—esophageal cancer	3.42e-05	0.000192	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—TPI1—esophageal cancer	3.42e-05	0.000192	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CREBBP—esophageal cancer	3.4e-05	0.000191	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—NOTCH1—esophageal cancer	3.39e-05	0.00019	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—SMAD4—esophageal cancer	3.36e-05	0.000188	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—SMAD4—esophageal cancer	3.36e-05	0.000188	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—EGFR—esophageal cancer	3.35e-05	0.000187	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—PIK3CA—esophageal cancer	3.34e-05	0.000187	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—ALDOB—esophageal cancer	3.28e-05	0.000184	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CCND1—esophageal cancer	3.25e-05	0.000182	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—TP53—esophageal cancer	3.23e-05	0.000181	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—PIK3CA—esophageal cancer	3.2e-05	0.000179	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—GAPDH—esophageal cancer	3.16e-05	0.000177	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CDKN1A—esophageal cancer	3.14e-05	0.000176	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CRABP1—esophageal cancer	3.13e-05	0.000175	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CREBBP—esophageal cancer	3.07e-05	0.000172	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—NOS3—esophageal cancer	3.05e-05	0.000171	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—EP300—esophageal cancer	3.04e-05	0.00017	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—EGFR—esophageal cancer	3.02e-05	0.000169	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—EP300—esophageal cancer	2.99e-05	0.000168	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.98e-05	0.000167	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—GNG7—esophageal cancer	2.97e-05	0.000167	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—PIK3CA—esophageal cancer	2.9e-05	0.000163	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—PIK3CA—esophageal cancer	2.88e-05	0.000162	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—ERBB2—esophageal cancer	2.85e-05	0.00016	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—HIF1A—esophageal cancer	2.81e-05	0.000158	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—ALDH2—esophageal cancer	2.79e-05	0.000156	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—HIF1A—esophageal cancer	2.75e-05	0.000154	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—HIF1A—esophageal cancer	2.75e-05	0.000154	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—NOS3—esophageal cancer	2.75e-05	0.000154	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—KDR—esophageal cancer	2.69e-05	0.000151	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—GSTT1—esophageal cancer	2.65e-05	0.000149	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—KDR—esophageal cancer	2.63e-05	0.000147	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—KDR—esophageal cancer	2.63e-05	0.000147	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CYP2A6—esophageal cancer	2.62e-05	0.000147	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—PIK3CA—esophageal cancer	2.62e-05	0.000147	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—MYC—esophageal cancer	2.61e-05	0.000146	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—ERBB2—esophageal cancer	2.57e-05	0.000144	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—EGFR—esophageal cancer	2.55e-05	0.000143	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—NOTCH1—esophageal cancer	2.53e-05	0.000142	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CCND1—esophageal cancer	2.52e-05	0.000141	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PTGS1—esophageal cancer	2.48e-05	0.000139	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—ENO1—esophageal cancer	2.48e-05	0.000139	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.48e-05	0.000139	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—NOTCH1—esophageal cancer	2.48e-05	0.000139	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—NOTCH1—esophageal cancer	2.48e-05	0.000139	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PSME1—esophageal cancer	2.45e-05	0.000137	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PSME2—esophageal cancer	2.45e-05	0.000137	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CDKN1A—esophageal cancer	2.44e-05	0.000137	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—EP300—esophageal cancer	2.32e-05	0.00013	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CREBBP—esophageal cancer	2.3e-05	0.000129	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CCND1—esophageal cancer	2.27e-05	0.000127	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—EGFR—esophageal cancer	2.26e-05	0.000126	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—PIK3CA—esophageal cancer	2.25e-05	0.000126	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CREBBP—esophageal cancer	2.25e-05	0.000126	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CREBBP—esophageal cancer	2.25e-05	0.000126	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—PIK3CA—esophageal cancer	2.21e-05	0.000124	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—EGFR—esophageal cancer	2.21e-05	0.000124	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—EGFR—esophageal cancer	2.21e-05	0.000124	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CDKN1A—esophageal cancer	2.2e-05	0.000123	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—PIK3CA—esophageal cancer	2.16e-05	0.000121	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—TP53—esophageal cancer	2.14e-05	0.00012	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CYP1B1—esophageal cancer	2.11e-05	0.000118	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—PIK3CA—esophageal cancer	2.11e-05	0.000118	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—PIK3CA—esophageal cancer	2.11e-05	0.000118	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—EP300—esophageal cancer	2.09e-05	0.000117	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—NOS3—esophageal cancer	2.06e-05	0.000115	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—MYC—esophageal cancer	2.02e-05	0.000113	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—NOS3—esophageal cancer	2.01e-05	0.000113	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—NOS3—esophageal cancer	2.01e-05	0.000113	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CYP19A1—esophageal cancer	1.99e-05	0.000111	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—EGFR—esophageal cancer	1.98e-05	0.000111	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—PIK3CA—esophageal cancer	1.96e-05	0.00011	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—ERBB2—esophageal cancer	1.92e-05	0.000108	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—PIK3CA—esophageal cancer	1.92e-05	0.000107	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—PIK3CA—esophageal cancer	1.92e-05	0.000107	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—ERBB2—esophageal cancer	1.88e-05	0.000105	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—ERBB2—esophageal cancer	1.88e-05	0.000105	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—MYC—esophageal cancer	1.82e-05	0.000102	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—HMOX1—esophageal cancer	1.81e-05	0.000102	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—EGFR—esophageal cancer	1.78e-05	9.99e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—ABCB1—esophageal cancer	1.74e-05	9.75e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—PIK3CA—esophageal cancer	1.72e-05	9.61e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CCND1—esophageal cancer	1.7e-05	9.52e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CCND1—esophageal cancer	1.66e-05	9.32e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CCND1—esophageal cancer	1.66e-05	9.32e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—TP53—esophageal cancer	1.66e-05	9.3e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CDKN1A—esophageal cancer	1.64e-05	9.21e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CDKN1A—esophageal cancer	1.61e-05	9.01e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CDKN1A—esophageal cancer	1.61e-05	9.01e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—EP300—esophageal cancer	1.56e-05	8.76e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PIK3CA—esophageal cancer	1.55e-05	8.67e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—EP300—esophageal cancer	1.53e-05	8.58e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—EP300—esophageal cancer	1.53e-05	8.58e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—TP53—esophageal cancer	1.5e-05	8.39e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—MYC—esophageal cancer	1.36e-05	7.64e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—MYC—esophageal cancer	1.33e-05	7.47e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—MYC—esophageal cancer	1.33e-05	7.47e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—EGFR—esophageal cancer	1.33e-05	7.47e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—EGFR—esophageal cancer	1.3e-05	7.31e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—EGFR—esophageal cancer	1.3e-05	7.31e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CREBBP—esophageal cancer	1.16e-05	6.52e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PIK3CA—esophageal cancer	1.16e-05	6.48e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PIK3CA—esophageal cancer	1.13e-05	6.35e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PIK3CA—esophageal cancer	1.13e-05	6.35e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—TP53—esophageal cancer	1.12e-05	6.27e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TP53—esophageal cancer	1.1e-05	6.14e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—TP53—esophageal cancer	1.1e-05	6.14e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—NOS3—esophageal cancer	1.04e-05	5.83e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PTGS2—esophageal cancer	9.52e-06	5.34e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—EP300—esophageal cancer	7.92e-06	4.44e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PIK3CA—esophageal cancer	5.86e-06	3.28e-05	CbGpPWpGaD
